RESUMO
Fungemia caused by Geotrichum spp. is rare and highly lethal. The Instituto Nacional de Cancerología in Bogotá reported just two cases: one in the period 2001-2007 and the other in 2012-2018. This type of infection is more common in any kind of immunocompromised patients, so it can occur in those with hematological malignancies. Here we present the case of a 27-year-old man, diagnosed with acute lymphoblastic leukemia in relapse and admitted with polyarthralgia for five days, febrile neutropenia, nonabscessed cellulitis, and bacteremia due to methicillin-sensitive Staphylococcus aureus. The patient received therapy with oxacillin and cefepime, but the febrile neutropenia persisted. A new set of blood cultures was taken, and antifungal treatment was started because of the suspicion of invasive fungal infection. Arthroconidia were identified in blood cultures and Geotrichum spp. was confirmed using matrix-assisted laser desorption-ionization mass spectrometry. The antifungal treatment was adjusted with amphotericin B deoxycholate for 14 days and voriconazole for four weeks, and after a prolonged stay, the patient was discharged. Although the incidence of fungemia caused by Geotrichum spp. is low, it must be considered in patients with hematological malignancies and persistent febrile neutropenia despite the broadspectrum antimicrobial treatment. The confirmation of fungemia causing agents, with proteomic tools such as the mentioned mass spectrometry, allows treatment adjustment and decreases complications, hospital stay, and mortality.
La fungemia por Geotrichum spp. es poco frecuente y altamente letal. En el Instituto Nacional de Cancerología de Bogotá solo se han reportado dos casos: uno entre el 2001 y el 2007, y el otro entre el 2012 y el 2018. Este tipo de infección es más común en pacientes con algún grado de compromiso del sistema inmunitario, por lo que puede presentarse en pacientes con neoplasias hematológicas malignas. Se presenta el caso de un hombre de 27 años con recaída de leucemia linfoblástica aguda, que ingresó con poliartralgias de cinco días de duración. También cursaba con neutropenia febril, celulitis sin abscesos y bacteriemia por Staphylococcus aureus resistente a la meticilina para lo cual recibió terapia con oxacilina y cefepime. Sin embargo, persistía la neutropenia febril por lo que se sospechó una infección fúngica invasora. Se tomó un nuevo set de hemocultivos y se inició tratamiento antifúngico. En los hemocultivos se identificaron artroconidias y mediante espectrometría de masas por láser de matriz asistida de ionización-desorción se confirmó la presencia de Geotrichum spp. Se ajustó el tratamiento antifúngico con deoxicolato de anfotericina B por 14 días y voriconazol por cuatro semanas. Luego de una estancia prolongada se le dio de alta. Aunque la incidencia de la fungemia por Geotrichum spp. es baja, en pacientes con neoplasias hematológicas malignas debe considerarse en el contexto de una neutropenia febril que es persistente a pesar del tratamiento antimicrobiano de amplio espectro.
Assuntos
Neutropenia Febril , Fungemia , Geotricose , Neoplasias Hematológicas , Leucemia-Linfoma Linfoblástico de Células Precursoras , Masculino , Humanos , Adulto , Fungemia/diagnóstico , Fungemia/tratamento farmacológico , Antifúngicos/uso terapêutico , Proteômica , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Neutropenia Febril/tratamento farmacológicoRESUMO
La fungemia por Geotrichum spp. es poco frecuente y altamente letal. En el Instituto Nacional de Cancerología de Bogotá solo se han reportado dos casos: uno entre el 2001 y el 2007, y el otro entre el 2012 y el 2018. Este tipo de infección es más común en pacientes con algún grado de compromiso del sistema inmunitario, por lo que puede presentarse en pacientes con neoplasias hematológicas malignas. Se presenta el caso de un hombre de 27 años con recaída de leucemia linfoblástica aguda, que ingresó con poliartralgias de cinco días de duración. También cursaba con neutropenia febril, celulitis sin abscesos y bacteriemia por Staphylococcus aureus resistente a la meticilina para lo cual recibió terapia con oxacilina y cefepime. Sin embargo, persistía la neutropenia febril por lo que se sospechó una infección fúngica invasora. Se tomó un nuevo set de hemocultivos y se inició tratamiento antifúngico. En los hemocultivos se identificaron artroconidias y mediante espectrometría de masas por láser de matriz asistida de ionización-desorción se confirmó la presencia de Geotrichum spp. Se ajustó el tratamiento antifúngico con deoxicolato de anfotericina B por 14 días y voriconazol por cuatro semanas. Luego de una estancia prolongada se le dio de alta. Aunque la incidencia de la fungemia por Geotrichum spp. es baja, en pacientes con neoplasias hematológicas malignas debe considerarse en el contexto de una neutropenia febril que es persistente a pesar del tratamiento antimicrobiano de amplio espectro. La identificación de los agentes causantes de fungemias con herramientas de proteómica, como la espectrometría de masas mencionada, permite ajustar el tratamiento dirigido y reducir las complicaciones, la estancia hospitalaria y la mortalidad.
Fungemia caused by Geotrichum spp. is rare and highly lethal. The Instituto Nacional de Cancerología in Bogotá reported just two cases: one in the period 2001-2007 and the other in 2012-2018. This type of infection is more common in any kind of immunocompromised patients, so it can occur in those with hematological malignancies. Here we present the case of a 27-year-old man, diagnosed with acute lymphoblastic leukemia in relapse and admitted with polyarthralgia for five days, febrile neutropenia, non- abscessed cellulitis, and bacteremia due to methicillin-sensitive Staphylococcus aureus. The patient received therapy with oxacillin and cefepime, but the febrile neutropenia persisted. A new set of blood cultures was taken, and antifungal treatment was started because of the suspicion of invasive fungal infection. Arthroconidia were identified in blood cultures and Geotrichum spp. was confirmed using matrix-assisted laser desorption-ionization mass spectrometry. The antifungal treatment was adjusted with amphotericin B deoxycholate for 14 days and voriconazole for four weeks, and after a prolonged stay, the patient was discharged. Although the incidence of fungemia caused by Geotrichum spp. is low, it must be considered in patients with hematological malignancies and persistent febrile neutropenia despite the broadspectrum antimicrobial treatment. The confirmation of fungemia causing agents, with proteomic tools such as the mentioned mass spectrometry, allows treatment adjustment and decreases complications, hospital stay, and mortality.
Assuntos
Leucemia-Linfoma Linfoblástico de Células Precursoras , Geotricose , Anfotericina B , Fungemia , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , VoriconazolRESUMO
RESUMEN Saprochaete capitata es una causa rara de infección fúngica invasiva en pacientes inmunocomprometidos con alta mortalidad y resistencia antifúngica. Presentamos el caso de un niño de cinco años con diagnóstico de aplasia medular, sometido a trasplante de progenitores hematopoyéticos (TPH), que cursó con neutropenia febril persistente, dolor abdominal intenso, aparición de lesiones maculopapulares en piel y deterioro de la función renal. Se identificó la presencia de S. capitata, en hemocultivos transcatéter venoso central. Esta infección fúngica invasiva resulta ser rara, pero emergente y potencialmente mortal, en pacientes con neutropenia febril persistente y uso prolongado de dispositivos invasivos intravasculares como catéter venoso central.
ABSTRACT Saprochaete capitata is a rare cause of invasive fungal infection in immunocompromised patients with high mortality and antifungal resistance. We present the case of a 5-year-old boy with bone marrow aplasia, who underwent hematopoietic stem cell transplantation (HSCT) and presented persistent febrile neutropenia, abdominal pain, appearance of maculopapular lesions on the skin, and impaired renal function. The presence of S. capitata was identified by blood culture from a central venous catheter. This invasive fungal infection is rare but emergent and life-threatening, especially in immunocompromised patients with persistent febrile neutropenia and prolonged use of invasive devices such as central venous catheters.
Assuntos
Humanos , Masculino , Pré-Escolar , Hospedeiro Imunocomprometido , Infecções Fúngicas Invasivas/microbiologia , Geotricose/microbiologia , Geotrichum/isolamento & purificação , Anemia Aplástica/complicações , Evolução Fatal , Infecções Fúngicas Invasivas/tratamento farmacológico , Geotricose/tratamento farmacológico , Antifúngicos/uso terapêuticoRESUMO
OBJECTIVES: Geotrichum spp can be responsible for severe infections in immunocompromised patients. We aim to describe Geotrichum-related infections in the ICU and to assess risk factors of mortality. METHODS: Retrospective multicentre study, conducted in 14 French ICUs between 2002 and 2018, including critically ill adult patients with proven or probable infection related to Geotrichum species. Data were obtained from the medical charts. RESULTS: Thirty-six patients, median age 60 years IQR [53; 66] were included. Most of the patients had haematological malignancies (78%). The reason for ICU admission was shock in half of the patients (n = 19, 53%) and respiratory failure in thirteen patients (36%). Median SOFA score was 8.5 IQR [7; 15]. Time between ICU admission and fungal diagnosis was 2.5 days [-1; 4]. Infection was disseminated in 27 (75%) patients with positive blood cultures in 25 patients (69%). Thirty patients (83%) received curative antifungal treatment in the ICU, in a median time of 1 day [0;1] after ICU admission. Twenty-four patients (67%) died in the ICU and hospital mortality rate was 69%. The number and extent of organ failures, as represented by SOFA score, were associated with mortality. CONCLUSIONS: This study demonstrates poor outcome in critically ill patients with Geotrichum-related infections, which encourages a high level of suspicion.
Assuntos
Estado Terminal , Geotricose/epidemiologia , Adulto , França , Geotrichum , Mortalidade Hospitalar , Humanos , Unidades de Terapia Intensiva , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
Magnusiomyces and Geotrichum species are ascomycetous yeasts that can cause potentially life-threatening invasive fungal infections commonly referred to as geotrichosis. In this study, we aimed to estimate the incidence and mortality of these infections in a German tertiary care center. Furthermore, we evaluated the suitability of the fungal biomarkers galactomannan (GM) and ß-1,3-d-glucan (BDG), which are both recommended as surrogate markers for Magnusiomyces capitatus infection by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) joint clinical guidelines for the diagnosis and management of rare invasive yeast infections for detection of invasive geotrichosis. Cases meeting the inclusion criteria for invasive Magnusiomyces/Geotrichum infection were retrospectively identified. Serum samples and culture supernatants were analyzed with two commercially available fungal antigen tests (Platelia Aspergillus Ag EIA and Wako ß-glucan test). For a control cohort, outpatient samples sent for lues testing were included. Thirty-eight cases of Magnusiomyces/Geotrichum infection were identified over an 11-year observation period. In the majority of cases, the fungus was isolated from intra-abdominal specimens of patients with a history of abdominal surgery/procedures (n = 32). All cases of fungemia occurred exclusively in haemato-oncologic patients (n = 14). Thirty-day survival was 42% in the fungemia and 43% in the intra-abdominal geotrichosis group. Serum samples were available for 23 patients (14 bloodstream and nine intra-abdominal infections). While BDG sensitivity was 65%, none of the sera was GM positive. This finding was supported by in vitro experiments analyzing fungal culture supernatants: M. capitatus secretes significant amounts of BDG but not GM. Specificity was 96% for BDG and 100% for GM. Magnusiomyces and Geotrichum infections are not limited to haemato-oncologic patients. Contrasting the current ESCMID/ECMM recommendation, our results indicate that GM is no suitable biomarker for the diagnosis of Magnusiomyces infection. Contrarily, BDG sensitivity is comparable to that of candidemia.
Assuntos
Geotricose , Geotrichum , Infecções Fúngicas Invasivas , Mananas , Proteoglicanas , Saccharomycetales , beta-Glucanas , Biomarcadores/sangue , Galactose/análogos & derivados , Geotricose/sangue , Geotricose/diagnóstico , Geotrichum/isolamento & purificação , Humanos , Infecções Fúngicas Invasivas/sangue , Infecções Fúngicas Invasivas/diagnóstico , Mananas/sangue , Proteoglicanas/sangue , Estudos Retrospectivos , Saccharomycetales/isolamento & purificação , Sensibilidade e Especificidade , beta-Glucanas/sangueRESUMO
There has been increasing reports of secondary bacterial and fungal infections associated with COVID-19. Following the initial reports of infection with Aspergillus spp., and Candida spp. there has been a significant rise in infections with Mucorales spp. In this case report, we present a case of Geotrichum spp. infection in an immunocompetent host with COVID-19. To our knowledge, this is the first case of Geotrichum infection in COVID-19. Geotrichum is a rare emerging pathogen that causes invasive disease, termed geotrichosis, which occurs in immunocompromised adult hosts with neutropenia. The development of invasive fungal infection such as Geotrichum in patients with SARS-CoV-2 infection requires a high degree of clinical suspicion and should be considered particularly in those who have an underlying immunocompromised state and those receiving corticosteroids or other immunosuppressive agents.
Assuntos
COVID-19 , Geotricose , Adulto , Antifúngicos/uso terapêutico , Geotricose/tratamento farmacológico , Geotrichum , Humanos , Hospedeiro Imunocomprometido , SARS-CoV-2Assuntos
Antineoplásicos/uso terapêutico , Fungemia/diagnóstico , Geotricose/diagnóstico , Leucemia/tratamento farmacológico , Doença Aguda , Adulto , Antineoplásicos/efeitos adversos , Fungemia/etiologia , Geotricose/etiologia , Geotrichum/isolamento & purificação , Humanos , Hospedeiro Imunocomprometido , Leucemia/microbiologia , Leucemia/patologia , Masculino , Pessoa de Meia-IdadeRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Fungemia/microbiologia , Geotricose/microbiologia , Evolução Fatal , Geotricose/complicações , Geotricose/diagnósticoAssuntos
Falso Aneurisma/diagnóstico por imagem , Falso Aneurisma/microbiologia , Geotricose/diagnóstico por imagem , Esplenopatias/diagnóstico por imagem , Esplenopatias/microbiologia , Falso Aneurisma/terapia , Antifúngicos/uso terapêutico , Angiografia por Tomografia Computadorizada , Diagnóstico Diferencial , Embolização Terapêutica , Fungemia/diagnóstico por imagem , Fungemia/microbiologia , Fungemia/terapia , Geotricose/terapia , Humanos , Hospedeiro Imunocomprometido , Leucemia Mieloide Aguda/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Esplenopatias/terapia , Ultrassonografia Doppler em CoresRESUMO
Invasive fungal infections are one of the vital complications among acute leukemia patients undergoing induction chemotherapy. Among them, Geotrichum clavatum infections present extremely rarely with atypical clinical symptoms which make them difficult to diagnose. In this paper, we report a case of infection caused by Geotrichum clavatum in a 10-year old child with acute leukemia, which is the first documented case from mainland China. With underlying childhood leukemia, the child suffered from recurrent bacterial and fungal infection and even underwent abdominal surgery during the treatment. Fortunately, the therapeutic effect was finally achieved by adjusting the treatment program to dual anti-fungal treatment with micafungin and amphotericin B. Information regarding the epidemiological, clinical, and therapeutic features, in this case, shows significant perspectives for anti-fungal treatment for immunocompromised individuals, wherefore the rate of recovery and survival can be achieved.
Assuntos
Geotricose/diagnóstico , Geotricose/patologia , Geotrichum/isolamento & purificação , Infecções Fúngicas Invasivas/etiologia , Infecções Fúngicas Invasivas/patologia , Leucemia/complicações , Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Criança , China , Geotricose/tratamento farmacológico , Humanos , Infecções Fúngicas Invasivas/tratamento farmacológico , Masculino , Micafungina/administração & dosagem , Resultado do TratamentoRESUMO
We are reporting the case of an 82-year-old Yemeni patient, renal transplant recipient who was admitted to our institution and who subsequently developed disseminated infection with Saprochaete capitata. This pathogenic fungus is rarely reported in patients with solid organ trans-plants. Saprochaete capitata is an emerging fungal pathogen, ubiquitously spread in the environment. This is the second case to our knowledge of infection with Saprochaete capitata in a renal transplant patient. Our patient was treated for multiple nosocomial infections with prolonged antibiotic courses. He succumbed to the infection with Saprochaete capitate after several weeks spent in the intensive care unit.
Assuntos
Infecção Hospitalar/microbiologia , Geotricose/microbiologia , Geotrichum/isolamento & purificação , Transplante de Rim/efeitos adversos , Idoso de 80 Anos ou mais , Antifúngicos/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Equinocandinas/uso terapêutico , Evolução Fatal , Fungemia/tratamento farmacológico , Fungemia/microbiologia , Geotricose/sangue , Geotricose/tratamento farmacológico , Geotrichum/patogenicidade , Humanos , Unidades de Terapia Intensiva , Masculino , TransplantadosRESUMO
Saprochaete capitata, formerly known as Geotrichum capitatum, is an emerging fungal pathogen with low susceptibility to echinocandins. Here, we report the nucleotide sequence of the S. capitata hot spot 1 region of the FKS gene (FKS HS1), which codifies for the catalytic subunit of ß-1,3-d-glucan synthase, the target of echinocandins. For that purpose, we first designed degenerated oligonucleotide primers derived from conserved flanking regions of the FKS1 HS1 segment of 12 different fungal species. Interestingly, analysis of the translated FKS HS1 sequences of 12 isolates of S. capitata revealed that all of them exhibited the same F-to-L substitution in a position that is highly related to reduced echinocandin susceptibility.
Assuntos
Antifúngicos/farmacologia , Farmacorresistência Fúngica/genética , Equinocandinas/farmacologia , Proteínas Fúngicas/genética , Regulação Fúngica da Expressão Gênica , Geotrichum/genética , Glucosiltransferases/genética , Substituição de Aminoácidos , Sequência de Bases , DNA Fúngico/genética , Proteínas Fúngicas/metabolismo , Geotricose/tratamento farmacológico , Geotricose/microbiologia , Geotricose/patologia , Geotrichum/efeitos dos fármacos , Geotrichum/crescimento & desenvolvimento , Geotrichum/isolamento & purificação , Glucosiltransferases/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Análise de Sequência de DNARESUMO
Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope™ registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.
Assuntos
Geotricose/microbiologia , Geotrichum/isolamento & purificação , Infecções Fúngicas Invasivas/microbiologia , Sistema de Registros , Saccharomycetales/isolamento & purificação , Adolescente , Adulto , Idoso , Anfotericina B/farmacologia , Anfotericina B/uso terapêutico , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Equinocandinas/farmacologia , Equinocandinas/uso terapêutico , Feminino , Fluconazol/farmacologia , Fluconazol/uso terapêutico , Fungemia/diagnóstico , Fungemia/tratamento farmacológico , Fungemia/microbiologia , Geotricose/tratamento farmacológico , Geotricose/mortalidade , Geotrichum/classificação , Geotrichum/efeitos dos fármacos , Geotrichum/genética , Humanos , Hospedeiro Imunocomprometido , Infecções Fúngicas Invasivas/tratamento farmacológico , Infecções Fúngicas Invasivas/mortalidade , Lipopeptídeos/farmacologia , Lipopeptídeos/uso terapêutico , Masculino , Micafungina , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Neutropenia/complicações , Neutropenia/tratamento farmacológico , Neutropenia/microbiologia , Saccharomycetales/classificação , Saccharomycetales/efeitos dos fármacos , Saccharomycetales/genética , Voriconazol/farmacologia , Voriconazol/uso terapêutico , Adulto JovemAssuntos
Antifúngicos/uso terapêutico , Celulite (Flegmão)/microbiologia , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Gastrostomia/efeitos adversos , Geotricose/tratamento farmacológico , Geotricose/microbiologia , Geotrichum , Infecção da Ferida Cirúrgica/tratamento farmacológico , Idoso de 80 Anos ou mais , Anfotericina B/uso terapêutico , Antifúngicos/farmacologia , Aspirina , Combinação de Medicamentos , Feminino , Flucitosina/uso terapêutico , Geotrichum/efeitos dos fármacos , Humanos , Óxido de Magnésio , Testes de Sensibilidade Microbiana , Infecção da Ferida Cirúrgica/microbiologiaRESUMO
Magnusiomyces capitatus may cause uncommon yet severe infections, especially in patients with haematologic disorders. Diagnosis may be difficult and time-consuming and newer approaches are required including the MALDI-TOF technique implemented with the detection of fungal antigens in the body fluids. The recommended treatment includes amphotericin B alone or in combination with flucytosine. We describe a case of a non-neutropenic patient with M. capitatus pleural infection, as identified by MALDI-TOF, positivity for galactomannan antigen in the BAL fluid, and successfully treated with oral posaconazole in single therapy.